In vitro selection of a viomycin-binding RNA pseudoknot

Chemistry and Biology

Volumn 4, Issue 5, 1997, Pages 357-366

  Wallis, Mary G ^a   Streicher, Barbara ^a   Wank, Herbert ^a,c   Von Ahsen, Uwe ^a,d   Clodi, Elisabeth ^a   Wallace, Scot T ^a   Famulok, Michael ^b   Schroeder, Renée ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF MUNICH   (Germany)

^c OHIO STATE UNIVERSITY   (United States)

^d RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

Antibiotics; In vitro selection; RNA aptamers; RNA pseudoknots; Viomycin

Indexed keywords

DELTA VIRUS; HEPATITIS DELTA VIRUS;

EID: 0031149880     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(97)90126-5     Document Type: Article

References (40)

1. Cundliffe, E. (1990). Recognition sites for antibiotics within rRNA. In The Ribosome. (Hill, W.E., Dahlberg, A., Garrett, R., Moore, P., Schlessinger, D. & Warner, J., eds), pp. 479-490, ASM, Washington, USA.
2. Von Ahsen, U., Davies, J. & Schroeder, R. (1991). Antibiotic inhibition of group I ribozyme function. Nature 353, 368-370.
3. Von Ahsen, U., Davies, J. & Schroeder, R. (1992). Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics. J. Mol. Biol. 226, 935-941.
4. Wank, H., Rogers, J., Davies, J. & Schroeder, R. (1994). Peptide antibiotics of the tuberactinomycin family as inhibitors of group I intron RNA splicing. J. Mol. Biol. 236, 1001-1010.
5. Rogers, J. & Davies, J. (1994). The pseudodisaccharides: a novel class of group I intron splicing inhibitors. Nucleic Acids Res. 22, 4983-4988.
6. Olive, J.E., et al., & Collins, R.A. (1995). Enhancement of Neurospora VS ribozyme cleavage by tuberactinomycin antibiotics. EMBO J. 14, 3247-3251.
7. Wank, H. & Schroeder, R. (1996). Antibiotic induced oligomerization of group I intron RNA. J. Mol. Biol. 258, 53-61.
8. Rogers, J., Chang, A.M., Von Ahsen, U., Schroeder, R. & Davies, J. (1996). Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics. J. Mol. Biol. 259, 916-925.
9. Schroeder, R. & Von Ahsen, U. (1996). Interaction of aminoglycoside antibiotics with RNA. In Nucleic Acids and Molecular Biology. (Eckstein, F. & Lilley, D.M.J., eds), pp. 53-74, Springer-Verlag, Heidelberg, Berlin, Germany.
10. Gold, L., Polisky, B., Uhlenbeck, O. & Yarus, M. (1995). Diversity of oligonucleotide functions. Annu. Rev. Biochem. 64, 763-797.
11. Wallis, M.G., Von Ahsen, U., Schroeder, R. & Famulok, M. (1995). A novel RNA motif for neomycin recognition. Chem. Biol. 2, 543-552.
12. Wang, Y. & Rando, R.R. (1995). Specific binding of aminoglycoside antibiotics to RNA. Chem. Biol. 2, 281-290.
13. Lato, S.M., Boles, A.R. & Ellington, A.D. (1995). In vitro selection of RNA lectins: using combinatorial chemistry to interpret ribozyme evolution. Chem. Biol. 2, 291-303.
14. Purohit, P. & Stern, S. (1994). Interactions of a small RNA with antibiotics and RNA ligands of the 30S subunit. Nature 370, 659-662.
15. Schroeder, R. (1994). Dissecting RNA function. Nature 370, 597-598.
16. Laing, L.G. & Draper, D.E. (1994). Thermodynamics of RNA folding in a conserved ribosomal RNA domain. J. Mol. Biol. 237, 560-576.
17. Davies, J. (1994). Inactivation of antibiotics and the dissemination of resistance genes. Science 264, 375-382.
18. Burgstaller, P. & Famulok, M. (1994). Isolation of RNA aptamers for biological cofactors by in vitro selection. Angew. Chem. Int. Ed. Engl. 33, 1084-1087.
19. Zuker, M., Jaeger, J.A. & Turner, D.H. (1991). A comparison of optimal and suboptimal RNA secondary structures predicted by free energy minimization with structures determined by phylogenetic comparison. Nucleic Acids Res. 19, 2707-2714.
20. Stern, S., Moazed, D. & Noller, H.F. (1988). Structural analysis of RNA using chemical and enzymatic probing monitored by primer extension. Methods Enzymol. 164, 481-489.
21. Gornicki, P., et al., & Ehresmann, C. (1989). Use of lead(II) to probe the structure of large RNAs. Conformation of the 3′ terminal domain of E coli 16S rRNA and its involvement in building the tRNA binding sites. J. Biomol. Struct. Dynam. 6, 971-984.
22. Puglisi, J.D., Wyatt, J.R. & Tinocco, I.J. (1991). RNA pseudoknots. Accts. Chem. Res. 24, 152-158.
23. Westhof, E. & Jaeger, L. (1992). RNA pseudoknots. Curr. Opin. Struct. Biol. 2, 327-333.
24. Kusmierek, J.T. & Singer, B. (1976). Sites of alkylation of poly(U) by agents of varying carcinogenicity and stability of products. Biochim. Biophys. Acta 442, 420-431.
25. Streicher, B., Von Ahsen, U. & Schroeder, R. (1993). Lead cleavage sites in the core of group I intron-RNA. Nucleic Acids Res. 21, 311-317.
26. Powers, T. & Noller, H. (1994). Selective perturbation of G530 of 16S rRNA by translational miscoding agents and a streptomycin-dependence mutation in protein S12. J. Mol. Biol. 235, 156-1 72.
27. Moazed, D. & Noller, H.F. (1987). Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. Biochimie 69, 879-884.
28. Modolell, J. & Vazquez, D. (1977). The inhibition of ribosomal translocation by viomycin. Eur. J. Biochem. 81, 491-497.
29. Liou, Y.F. & Tanaka, N. (1976). Dual actions of viomycin on the ribosomal functions. Biochem. Biophys. Res. Commun. 71, 477-483.
30. Hornig, H., Woolley, P. & Luhrmann, R. (1983). Effect of codon shortening and the antibiotics viomycin and sparsomycin upon the behaviour of bound aminoacyl-tRNA. Decoding at the ribosomal A site. FEBS Lett. 156, 311-315.
31. Masquida, B., Felden, B. & Westhof, E. (1997). Context dependent RNA-RNA recognition in a three-dimensional model of the 16S rRNA core. Bioorg. Med. Chem., in press.
32. Michel, F., Hanna, M., Green, R., Bartel, D.P. & Szostak, J.W. (1989). The guanosine binding site of the Tetrahymena ribozyme. Nature 342, 391-395.
33. Michel, F. & Westhof, E. (1990). Modelling of the three-dimensional architecture of group I catalytic introns based on comparative sequence analysis. J. Mol. Biol. 216, 585-610.
34. Perrotta, A.T. & Been, M.D. (1991). A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature 350, 434-436.
35. Tanner, N.K., Schaff, S., Thill, G., Petit Koskas, E., Crain Denoyelle, A.M. & Westhof, E. (1994). A three-dimensional model of hepatitis delta virus ribozyme based on biochemical and mutational analyses. Curr. Biol. 4, 488-498.
36. Dam, E., Pleij, K. & Draper, D. (1992). Structural and functional aspects of RNA pseudoknots. Biochemistry 31, 11665-11676.
37. Famulok, M. (1994). Molecular recognition of amino acids by RNA-aptamers: an L-citrulline binding RNA motif and its evolution into an L-arginine binder. J. Am. Chem. Soc. 116, 1698-1706.
38. Hummel, J.P. & Dreyer, W.J. (1962). Measurement of protein-binding phenomena by gel filtration. Biochim. Biophys. Acta 63, 530-532.
39. 14C)tuberactinomycin O, an antibiotic closely related to viomycin, to the bacterial ribosome. Biochem. Biophys. Res. Commun. 82, 971-976.
40. Wank, H. (1996). Interactions of tuberactinomycins with group I intron RNA. PhD thesis, University of Vienna, Austria.